External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

MDS 2020

-
Coming soon
04:30 PM
Duration 61mins Virtual
A new horizon: how will slowing disease progression in Huntington's and Parkinson's disease transform patient care?
Jo Jankovic, Jody Corey Bloom, Tanya Simuni

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:30 PM
Duration 30mins Virtual
Antisense Oligonucleotides for Treating Movement Disorders: Current Status of Clinical Development
Lauren Boak

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
02:30 PM
Duration 10mins Virtual
PASADENA: A Phase 2 study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease: Part 1 Week-52 results
Gennaro Pagano, Kirsten I Taylor, Judith Anzures Cabrera, Maddalena Marchesi, Wagner Zago, Radhika Tripuraneni, Anne Boulay, Annamarie Vogt, Frank G Boess, Tania Nikolcheva, Hanno Svoboda, Markus Britschgi, Florian Lipsmeier, Michael Lindemann, Sebastian Dziadek, Jean-Philippe Azulay, Brit Mollenhauer, Lydia Lopez Manzanares, David S Russell, James T Boyd, Anthony P Nicholas, María R Luquin, Robert A Hauser, Tanya Simuni, Thomas Gasser, Werner Poewe, Gene G Kinney Rachelle Doody, Paulo Fontoura, Daniel Umbricht, and Azad Bonni

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar